Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03411291 · ClinicalTrials.gov registry record

Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study

A clinical trial, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
18
Enrollment target

NCT03411291 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03411291 has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
18 participants
Enrollment target

Study Summary

Specific Aim: Demonstrate that statins have an effect on cerebral blood flow and neuronal activity

Interventions

  • DEVICE MRI, MR Spectroscopy, MR Perfusion

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2007-04
Est. Completion 2010-09

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT03411291

The ClinicalTrials.gov registry entry for NCT03411291 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which MRI, MR Spectroscopy, MR Perfusion is the first listed.

NCT03411291 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03411291 about?

NCT03411291 is a clinical study titled "Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study". Specific Aim: Demonstrate that statins have an effect on cerebral blood flow and neuronal activity

What is the current status of trial NCT03411291?

This trial is currently completed. The enrollment target is 18 participants. The study started on 2007-04. Estimated completion is 2010-09.

What interventions are being tested in trial NCT03411291?

The interventions under investigation include: MRI, MR Spectroscopy, MR Perfusion (DEVICE).

Who is sponsoring clinical trial NCT03411291?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.